Filter
140
Filtered Results: 140
Text search:
European
Society
of
Cardiology
Featured
Recommendations
9
New Publications
19
Language
Document type
Studies & Reports
46
No document type
42
Guidelines
28
Strategic & Response Plan
9
Manuals
7
Fact sheets
5
Training Material
1
Situation Updates
1
Infographics
1
Countries / Regions
Western and Central Europe
7
Indonesia
6
India
5
Eastern Europe
5
Brazil
4
Global
4
Latin America and the Carribbean
3
Africa
3
Senegal
2
Philippines
2
Syria
2
Kenya
2
Mozambique
2
Argentina
2
Venezuela
2
Nigeria
1
USA
1
South Sudan
1
Germany
1
Zambia
1
Turkey
1
Tanzania
1
China
1
South Africa
1
Benin
1
North Macedonia
1
Hungary
1
Libya
1
East and Southern Africa
1
West and Central Africa
1
Middle East and North Africa
1
South–East Asia Region
1
Other region
1
Paraguay
1
Asia
1
Poland
1
Russia
1
Qatar
1
Lithuania
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
47
Clinical Guidelines
23
Public Health
21
Key Resources
5
Pharmacy & Technologies
2
Women & Child Health
1
Toolboxes
NCDs
37
COVID-19
23
Mental Health
9
TB
4
Caregiver
4
Conflict
3
Global Health Education
3
AMR
3
Planetary Health
3
Disability
2
Rapid Response
2
Refugee
1
HIV
1
Pharmacy
1
NTDs
1
Addressing comorbidity between mental disorders and major noncommunicable diseases (Russian Version)
Guide technique pour la prise en charge des maladies cardiovasculaires dans le cadre des soins de santé primaires
The World Heart Federation (WHF) is a leading global advocate for stronger legislation and policies regarding cardiovascular disease (CVD) and its risk factors, including raised cholesterol. The present Cholesterol Advocacy Toolkit 2022 provides WHF member organizations with information as well as p...
Настоящее руководство «Клиническое ведение случаев COVID-19» базируется на
вышеуказанных стратегических приоритетах и адресовано клиницистам, участвующим в
оказа...
Therapeutic Guidelines for Using Implant Cardiovascular Electronic Device in Indonesia
Hypertension and COVID-19: Scientific report - 17 June 2021
MSF الإرشادات السريرية. دليل التشخيص والعلاج
recommended
Clinical Guidelines. Diagnosis and Treatment Manual.
Estas Normas pretendem ser um instrumento de apoio ao profissional
de saúde afecto às Unidades Sanitárias, à todos os níveis de atenção de
saúde para o diagnóstico, tratamento e seguimento da HTA, bem como
prevenção das complicações
Los módulos que conforman el paquete técnico HEARTS están dirigidos a los formuladores de políticas públicas y gerentes, directores o coordinadores de programas a diferentes niveles dentro de los ministerios de salud cuyo trabajo influye sobre la prestación de servicios de salud a nivel prima...
Note d’information scientifique, 17 juin 2021
Stand 2.10.2020
El presente documento constituye la versión breve de la “Guía de Práctica Clínica (GPC) Nacional de Prevención, Diagnóstico y Tratamiento de la Hipertensión Arterial 2019” y forma parte del conjunto de acciones que el Ministerio de Salud de la Nación (MSN) lleva adelante para mejorar la ...
En 2015, murieron 5,9 millones de niños menores de cinco años (1). Las principales causas de muerte en los niños a nivel mundial son la neumonía, la prematuridad, las complicaciones durante el parto, la sepsis neonatal, las anomalías congénitas, las enfermedades diarreicas, las lesiones ...
En 2015, 5,9 millions d'enfants de moins de cinq ans sont décédés (1). Les principales causes de mortalité infantile dans le monde sont la pneumonie, la prématurité, les complications durant l'accouchement, la septicémie néonatale, les anomalies congénitales, la diarrhée, les tra...
Las infecciones del sitio quirúrgico (ISQ) constituyen una de las Infecciones Asociadas al Cuidado de la Salud (IACS) más frecuentes que ponen en riesgo a los pacientes llevando muchas veces al fracaso del procedimiento quirúrgico. Con una incidencia mucho mayor en países de medianos y bajos ing...
ESTA NOTA INFORMATIVA SUBSTITUI A NOTA INFORMATIVA Nº 11/2020-SE/GAB/SE/MS, DE 15 DE JUNHO DE 2020, QUE SUBSTITUIU A NOTA INFORMATIVANº 9/2020-SE/GAB/SE/MS, DE 20 DE MAIO DE 2020
(7th Version)
20, March 2020
Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the
leading cause of premature mortality in low and middle income countries (LMICs).
Identifying and managing individuals at high risk ... CVD is an important strategy to prevent and control CVD, in addition to multisectoral population-based interventions to reduce CVD risk factors in the entire population.
Methods: We describe key public health considerations in identifying and managing individuals at high risk of CVD in LMICs.
Results: A main objective of any strategy to identify individuals at high CVD risk is to maximize the number of CVD events averted while minimizing the numbers of
individuals needing treatment. Scores estimating the total risk of CVD (e.g. ten-year risk of fatal and non-fatal CVD) are available for LMICs, and are based on the main CVD risk factors (history of CVD, age, sex, tobacco use, blood pressure, blood cholesterol and diabetes status). Opportunistic screening of CVD risk factors enables identification of persons with high CVD risk, but this strategy can be widely applied in low resource settings only if cost effective interventions are used (e.g. the WHO Package of Essential NCD interventions for primary health care in low resource settings package) and if treatment (generally for years) can be sustained, including continued availability ofaffordable medications and funding mechanisms that allow people to purchase medications without impoverishing them (e.g. universal access to health care). Thisalso emphasises the need to re-orient health systems in LMICs towards chronic diseases management.
Conclusion: The large burden of CVD in LMICs and the fact that persons with high
CVD can be identified and managed along cost-effective interventions mean that
health systems need to be structured in a way that encourages patient registration, opportunistic screening of CVD risk factors, efficient procedures for the management of chronic conditions (e.g. task sharing) and provision of affordable treatment for those with high CVD risk. The focus needs to be in primary care because that is where most of the population can access health care and because CVD programmes can be run effectively at this level.
